CHMP Meeting to Discuss Review of Multaq
CHMP will have a meeting Friday to discuss the ongoing review of the benefits and risks of Multaq (dronedarone).
The European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP) is to have a meeting this Friday to discuss the ongoing review of the benefits and risks of Multaq (dronedarone).
Multaq has been authorised in the European Union since November 2009 for use in patients with atrial fibrillation, a condition where the upper chambers of the heart contract rapidly and in an irregular fashion.
The current review of Multaq began in January 2011 on the request of the European Commission, following reports of liver damage in two patients taking the medicine. In July 2011, the scope of the review was extended to also look at new data related to the effects of the medicine on the heart, blood vessels and lungs.
&n
Related News
-
News CPHI Americas 2026 - From the Floor
Our From the Floor live blog returns to Philadelphia for CPHI Americas 2026, continuing to showcase the entire pharmaceutical supply chain from north to south across the Americas.
-
News DCAT Week 2026: Insights from Thermo Fisher Scientific
Anil Kane, PhD, MBA, serves as the Executive Director and Global Head of Technical & Scientific Affairs at Thermo Fisher Scientific, a global leader in scientific research and innovation. In this exclusive interview, Kane shares his and Thermo Fisher&#... -
News A Day in the Life of a CPHI Attendee
The series aims to highlight some of the indispensable talent involved in all aspects of the pharma value chain, getting to know the people working towards better healthcare across the world. This special edition aims to get to know the people attendin... -
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Packaging Under Pressure: Where Sustainability in Pharma Meets Reality
A Reflection on the Sustainability Collective Roundtable Session at Pharmapack 2026
-
News Where Pharma Innovation Takes the Spotlight: Pharmapack Awards 2026
The 2026 Pharmapack Awards, held January 21, 2026, celebrated and recognised leading companies in the pharmaceutical packaging sector paving the way for packaging and drug delivery excellence in the future.
-
News Pharmapack 2026 - From the Floor
Celebrating its 25th anniversary in the city where it all started, Pharmapack 2026 is back in Paris! From January 21-22, 2026, Paris Expo Porte de Versailles opens its doors again to the pharmaceutical packaging and drug delivery sectors, ready for 2 d... -
News Reshaping Pharmaceutical Packaging’s Sustainable Future at Pharmapack 2026
Pharmapack 2026 returns as the pharmaceutical packaging industry's premier gathering, bringing together global leaders, innovators, and decision-makers for an unparalleled showcase of cutting-edge solutions and strategic insights.